ArticleFrontiers in pharmacology2022

Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis

Lei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.